Aug. 16, 2012—A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy, and may offer a way to further refine personalized cancer treatments.
Aug. 16, 2012—Efforts to improve quality of care at Vanderbilt have expanded rapidly in recent years. Notable achievements such as the central line-associated blood stream infections (CLABSI) reduction program — recently lauded for achieving infection levels significantly lower than the national average — have put Vanderbilt in the spotlight as a leader of such efforts. The CLABSI...
Aug. 13, 2012—Leaders with Cookeville Regional Medical Center (CRMC) and Vanderbilt University Medical Center announced an affiliation agreement that formalizes collaborative relationships between the two institutions.
Aug. 9, 2012—A new 3-D view of the body’s response to infection — and the ability to identify proteins involved in the response — could point to novel biomarkers and therapeutic agents for infectious diseases.
Aug. 9, 2012—Maryville, Tenn., tucked in the foothills of the Great Smoky Mountains, has a population of just 27,000, but it seemed like every one of its residents rallied around 20-year-old Brently Mancini when he was diagnosed with a rare soft tissue cancer.
Aug. 2, 2012—July 23 was the first day of class for the VUSM class of 2016, a little more than a week earlier than the start of last year’s classes.
Aug. 2, 2012—Two proteins that act in opposing directions – one that promotes cancer and one that suppresses cancer — regulate the same set of genes in prostate cancer, Vanderbilt-Ingram Cancer Center researchers have found.
Aug. 2, 2012—An ancient enzyme that can be traced back 500 million years forms the chemical “rivet” that reinforces connective tissue throughout the body, Vanderbilt University researchers reported this week.
Jul. 31, 2012—A type I diabetes prevention study that is part of the TrialNet program at Vanderbilt is now enrolling children as young as 8 years old.